Honolulu, HAWAII4 Active Studies

Pulmonary Embolism Clinical Trials in Honolulu, HAWAII

Find 4 actively recruiting pulmonary embolism clinical trials in Honolulu, HAWAII. Connect with local research sites and explore new treatment options.

4
Active Trials
1
Sponsors
2,853
Enrolling

Recruiting Pulmonary Embolism Studies in Honolulu

RecruitingHonolulu, HAWAIINCT06948422

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

The GZPL master protocol will support 2 independent studies, J2A-MC-GZL1 (GZL1) and J2A-MC-GZL2 (GZL2). The purpose of this study is to create a framework to evaluate the safety and efficacy of orforg...

974 participants
Eli Lilly and Company
View Study Details
RecruitingHonolulu, HAWAIINCT06914895

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 week...

905 participants
Eli Lilly and Company
View Study Details
RecruitingHonolulu, HAWAIINCT06948435

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweig...

487 participants
Eli Lilly and Company
View Study Details
RecruitingHonolulu, HAWAIINCT06952530

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

GZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or ov...

487 participants
Eli Lilly and Company
View Study Details

About Pulmonary Embolism Clinical Trials in Honolulu

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 4 pulmonary embolism clinical trials recruiting participants in Honolulu, HAWAII. These studies are seeking a combined 2,853 participants. Research is being sponsored by Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Honolulu — FAQ

Are there pulmonary embolism clinical trials in Honolulu?

Yes, there are 4 pulmonary embolism clinical trials currently recruiting in Honolulu, HAWAII. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Honolulu?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Honolulu research site will contact you about next steps.

Are clinical trials in Honolulu free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Honolulu studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 4 active trials in Honolulu are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov